Literature DB >> 24759678

Analysis of HLA-G gene polymorphism and protein expression in invasive breast ductal carcinoma.

Caroline Steglich Ramos1, Andréia Souza Gonçalves2, Larissa Cardoso Marinho3, Melissa Ameloti Gomes Avelino4, Vera Aparecida Saddi5, Aryanne Cristina Lopes3, Renata Toscano Simões6, Isabela Jubé Wastowski7.   

Abstract

The human leukocyte antigen G (HLA-G) is a non-classical HLA class I molecule predominantly expressed in trophoblastic placental cells to protect the fetus during pregnancy. However, evidence has shown that this molecule may be implicated in the immune escape mechanism of tumor cells. Thus, the aim of this study was to evaluate the frequency of 14-bp insertion/deletion HLA-G polymorphism, as well as the expression of this molecule in patients with invasive breast ductal carcinoma (IDC). A significant association between the expression of HLA-G and the presence of metastasis in lymph nodes (p=0.01) was observed and the expression of HLA-G was significantly higher in patients with shorter survival time (p=0.03). The analysis suggests that the polymorphism observed in patients with IDC may be inducing a higher expression of the HLA-G molecule, which may possibly contribute to shorter survival time and a worse clinical prognosis for such patients.
Copyright © 2014 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer; HLA-G; Polymorphism; Tumor escape

Mesh:

Substances:

Year:  2014        PMID: 24759678     DOI: 10.1016/j.humimm.2014.04.005

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  14 in total

1.  Relevance between HLA-DP gene rs2281388 polymorphism and hepatocellular carcinoma risk.

Authors:  Fangfeng Liu; Jianlu Wang; Hong Chang; Jun Lu; Hongguang Li
Journal:  Int J Clin Exp Pathol       Date:  2015-06-01

2.  Association of HLA-G +3142 C>G polymorphism and breast cancer in Tunisian population.

Authors:  Inès Zidi; Olfa Dziri; Nour Zidi; Refaat Sebai; Nadia Boujelebene; Amna Ben Hassine; Hamza Ben Yahia; Ahmed Baligh Laaribi; Wafa Babay; Hela Rifi; Amel Mezlini; Hanene Chelbi
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

3.  Genetic polymorphism in HLA-G 3'UTR 14-bp ins/del and risk of cancer: a meta-analysis of case-control study.

Authors:  Tao Li; Haohai Huang; Dan Liao; Huahuang Ling; Bingguang Su; Maode Cai
Journal:  Mol Genet Genomics       Date:  2015-01-09       Impact factor: 3.291

4.  Human Leukocyte Antigen-G (HLA-G) Expression in Cancers: Roles in Immune Evasion, Metastasis and Target for Therapy.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Mol Med       Date:  2015-08-24       Impact factor: 6.354

Review 5.  The Role of HLA-G Molecule and HLA-G Gene Polymorphisms in Tumors, Viral Hepatitis, and Parasitic Diseases.

Authors:  Fabrício C Dias; Erick C Castelli; Cristhianna V A Collares; Philippe Moreau; Eduardo A Donadi
Journal:  Front Immunol       Date:  2015-02-02       Impact factor: 7.561

6.  Characterization of HLA-G Regulation and HLA Expression in Breast Cancer and Malignant Melanoma Cell Lines upon IFN-γ Stimulation and Inhibition of DNA Methylation.

Authors:  Nanna Jørgensen; Abid Sayed; Helene Bjerregaard Jeppesen; Gry Persson; Iben Weisdorf; Tina Funck; Thomas Vauvert Faurschou Hviid
Journal:  Int J Mol Sci       Date:  2020-06-17       Impact factor: 5.923

Review 7.  Heterogeneity of HLA-G Expression in Cancers: Facing the Challenges.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2018-09-27       Impact factor: 7.561

8.  Human leukocyte antigen-G expression and polymorphisms promote cancer development and guide cancer diagnosis/treatment.

Authors:  Yanwen Zhang; Shuwen Yu; Yali Han; Yunshan Wang; Yuping Sun
Journal:  Oncol Lett       Date:  2017-11-14       Impact factor: 2.967

9.  Predicting the most deleterious missense nsSNPs of the protein isoforms of the human HLA-G gene and in silico evaluation of their structural and functional consequences.

Authors:  Elaheh Emadi; Fatemeh Akhoundi; Seyed Mehdi Kalantar; Modjtaba Emadi-Baygi
Journal:  BMC Genet       Date:  2020-08-31       Impact factor: 2.797

Review 10.  HLA-G/ILTs Targeted Solid Cancer Immunotherapy: Opportunities and Challenges.

Authors:  Aifen Lin; Wei-Hua Yan
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.